Ivan Horak

Ivan Horak

Nessuna posizione attualmente
75 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Dr. Ivan D.
Horak
, MD, is a Chief Executive Officer & Director at Tikva Allocell Pte Ltd., a Member at American Association for Cancer Research, a Member at American Society of Clinical Oncology, Inc., a Member at American Society of Hematology and a Venture Advisor at Israel Biotech Fund.
He is on the Board of Directors at Tikva Allocell Pte Ltd. Dr. Horak was previously employed as a Chief Medical & Scientific Officer by Tessa Therapeutics Ltd, a Chief Scientific Officer by Enzon Pharmaceuticals, Inc., a Chief Scientific Officer & Executive VP by Immunomedics, Inc., a Vice President-Clinical Oncology by Pharmacia Corp., a Director-Oncology Clinical Research & Development by The Janssen Research Foundation, a Principal by American College of Physicians, Inc. /Old/, and a Member by Union for International Cancer Control.
He received his doctorate degree from the University of Commenius.

Posizioni attive di Ivan Horak

SocietàPosizioneInizio
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Consulente / Consigliere -

Precedenti posizioni note di Ivan Horak

SocietàPosizioneFine
Direttore Tecnico/Scientifico/R&S 04/04/2011
IMMUNOMEDICS, INC. Direttore Tecnico/Scientifico/R&S 02/09/2005
Corporate Officer/Principal 01/05/2002
The Janssen Research Foundation
Direttore Tecnico/Scientifico/R&S 01/01/1999
Presidente -
Vedi nel dettaglio l'esperienza di Ivan Horak

Formazione di Ivan Horak

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

79

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private12

Health Technology

Health Technology

Union for International Cancer Control

Health Technology

Consumer Services

Health Services

Commercial Services

Commercial Services

Commercial Services

The Janssen Research Foundation

Health Technology

Finance

  1. Mercati
  2. Insiders
  3. Ivan Horak
40% di sconto: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA